| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |